Consolidated Income Statements (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Consolidated Income Statements [Abstract]
Revenue	$ 2,119	$ 1,908	$ 1,770
Costs of revenue	1,464	1,301	1,207
Gross profit	655	607	563
Sales and marketing expenses	167	166	149
General and administrative expenses	168	176	201
Research and development expenses	66	61	53
Restructuring and asset impairment charges, net	5	3	43
Asbestos-related costs, net	100	385	238
Transformation costs	396	0	0
Operating loss	(247)	(184)	(121)
Interest expense	76	97	98
Interest income	4	11	17
Miscellaneous (income) expense, net	(1)	6	6
Loss from continuing operations before income tax expense (benefit)	(318)	(276)	(208)
Income tax expense (benefit)	260	(144)	(97)
Loss from continuing operations	(578)	(132)	(111)
Income from discontinued operations, including tax expense of $237, $330 and $275, respectively	448	807	740
Gain on sale of discontinued operation, including tax benefit of $4	0	129	0
Net (loss) income	$ (130)	$ 804	$ 629
Basic and Diluted Earnings Per Share:
Continuing operations	$ (6.23)	$ (1.44)	$ (1.21)
Basic and diluted earnings per share related to discontinued operations	$ 4.83	$ 10.19	$ 8.10
Net income	$ 1.40	$ 8.75	$ 6.89
Weighted average common shares-basic and diluted	92.8	92.0	91.3
Cash dividends declared per common share	$ 1.591	$ 2.00	$ 1.70